HOME >> BIOLOGY >> NEWS
Whole-genome study at Johns Hopkins reveals a new gene associated with abnormal heart rhythm

Using a new genomic strategy that has the power to survey the entire human genome and identify genes with common variants that contribute to complex diseases, researchers at Johns Hopkins, together with scientists from Munich, Germany, and the Framingham Heart Study, U.S.A., have identified a gene that may predispose some people to abnormal heart rhythms that lead to sudden cardiac death, a condition affecting more than 300 thousand Americans each year.

The gene called NOS1AP, not previously flagged by or suspected from more traditional gene-hunting approaches, appears to influence significantly one particular risk factor - the so-called QT interval length - for sudden cardiac death. The work will be published online at Nature Genetics on April 30.

"In addition to finding a genetic variant that could be of clinical value for sudden cardiac death, this study also demonstrates how valuable large-scale genomics studies can be in detecting novel biological targets," says the study's senior author, Aravinda Chakravarti, Ph.D., director of the McKusick-Nathans Institute for Genetic Medicine at Hopkins. "This study, conducted during the early days of a new technology, would have been impossible without the pioneering support of the D.W. Reynolds Foundation in their generous support of our clinical program in sudden cardiac death here at Hopkins."

QT interval measures the period of time it takes the heart to recover from the ventricular beat - when the two bottom chambers of the heart pump. Corresponding to the "lub" part of the "lub-dub" pattern of the heartbeat, an individual's QT interval remains constant. This interval is partly dependent on one's genetic constitution and, moreover, genes also play a role in sudden cardiac death.

"There's a great deal of evidence out there that having a too long or too short QT interval is a risk factor for sudden cardiac death," says the study's co-first author, Dan Arking, Ph.D., an instructor in the
'"/>

Contact: Audrey Huang
audrey@jhmi.edu
410-614-5105
Johns Hopkins Medical Institutions
30-Apr-2006


Page: 1 2 3

Related biology news :

1. New study warns limited carbon market puts 20 percent of tropical forest at risk
2. Clones on task serve greater good, evolutionary study shows
3. Pollution causes 40 percent of deaths worldwide, study finds
4. A study by the MUHC and McGill University opens a new door to understanding cancer
5. New study suggests Concord grape juice may provide protection against breast cancer
6. Preclinical study links gene to brain aneurysm formation
7. In limiting life span, study finds booming bacteria innocent
8. Multicenter study nets new lung tumor-suppressor gene
9. MIT study: Maturity brings richer memories
10. Chickadee, nutchatch presence in conifers increases tree growth, says CU-Boulder study
11. Phase II study of therapeutic vaccine shows efficacy in patients with metastatic colorectal cancer

Post Your Comments:
(Date:6/14/2013)... GPS tracking collars to study hunting cheetahs in Botswana have ... village for a BBC programme. The BBC also deployed cat-cams ... the cat was moving. ,The Secret Life of The Cat, ... 2013 at 21:00., In a first study of its kind ... far they roamed and what they got up to once ...
(Date:6/14/2013)... Spain, 12 June 2013: Data presented at EULAR 2013, ... show that novel antibody biomarkers could significantly improve diagnosis ... UH-RA.1, UH-RA.9, UH-RA.14 and UH-RA.21 were investigated; ... and were present in both early and seronegative ... RF- and ACCP -negative patients testing positive. , ...
(Date:6/13/2013)... called "the microtubule network" is a crucial part ... transportation system within nerve cells, carrying essential proteins ... like Alzheimer,s, ALS, and Parkinson,s, this network breaks ... , Now Prof. Illana Gozes of Tel Aviv ... new peptide in her lab, called NAP or ...
Breaking Biology News(10 mins):From Botswanan big cats to Surrey house cats 2A peptide to protect brain function 2
(Date:6/15/2013)... The topics that will be covered in the ... roles, scrum meetings, scrum artifacts, and scrum simulation (optional). ... for attending them. , These trainings are suitable for ... is also ideal for those who will be a ... industry or those who want to explore Agile and ...
(Date:6/14/2013)... The OpenClinica Global Conference is ... year with Formedix CEO, Mark Wheeldon presenting as part ... a deeper insight into the future developments at OpenClinica ... Formedix to develop innovative solutions. , The conference program ... OpenClinica, hear real-life case studies and discover more about ...
(Date:6/14/2013)... SOUTH EASTON, Mass. , June 14, 2013 /PRNewswire/ ... today announced that it has closed the third and ... Convertible Preferred Stock and Warrants (the "Series J Private ... February 6 and $156,900 on March 28, 2013), the ... its Series J Private Placement, slightly over its goal ...
(Date:6/13/2013)... 2013 Eagle Biosciences is proud ... new Calprotectin ELISA assay kit that ... assay (1-2000 µg/g stool). The Calprotectin ELISA assay ... of human Calprotectin (neutrophil cytoplasmic protein s100A8/A9, MRP ... EagleBio’s gastrointestinal assay line which already includes Alpha ...
Breaking Biology Technology:Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 2Affordable Scrum Trainings in Chicago on July 12th 2013 by Conscires Agile Practices 3Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 2Formedix CEO Invited to Speak at OpenClinica Global Conference in Boston 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 2Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 3Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 4Pressure BioSciences, Inc. Closes Final Tranche of Series J Above Market Private Placement - Total Amount Raised in PIPE Slightly Exceeds $2 Million Goal 5Eagle Biosciences Introduces Highly Sensitive Calprotectin ELISA Assay Kit 2
Cached News: